BIOMAT Database Logo BIOMAT Database Logo

Antibodies to recombinant HIV-1 vif, tat, and nef proteins in human sera. 1990

U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Institut für Medizinische Virologie, Universität Heidelberg, Federal Republic of Germany.

The prevalence of antibodies against HIV-1 regulatory proteins in sera of HIV-infected patients from different stages of disease was investigated. HIV-1 vif, tat, and nef genes were cloned in procaryotic vectors and were expressed as MS-2 fusion proteins (vif and nef) or as a non-fusion protein (tat). These recombinant proteins were employed in immunoblot experiments. The specificity of the recognition was confirmed by competition experiments and with control sera from HIV-negative patients. Analysis of 136 serum samples revealed a high percentage of antibodies against nef, irrespective of the stage of disease. Antibodies against tat were found less frequently and increased from 16% to 40% with disease progression. Vif antibodies were detected only in a low percentage in early stages of disease, but their prevalence increased to 36% and 72% with progression of disease to AIDS-related complex and AIDS. Our data suggest that the detection of antibodies against nef may represent an additional and useful marker for the diagnosis of HIV infection, whereas the detection of vif antibodies may indicate disease progression.

UI MeSH Term Description Entries
D010957 Plasmids Extrachromosomal, usually CIRCULAR DNA molecules that are self-replicating and transferable from one organism to another. They are found in a variety of bacterial, archaeal, fungal, algal, and plant species. They are used in GENETIC ENGINEERING as CLONING VECTORS. Episomes,Episome,Plasmid
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015528 HIV Seroprevalence Studies of the number of cases where human immunodeficiency virus (HIV) is present in a specific population at a designated time. The presence in a given individual is determined by the finding of HIV antibodies in the serum (HIV SEROPOSITIVITY). Seroprevalence, HIV
D015534 Trans-Activators Diffusible gene products that act on homologous or heterologous molecules of viral or cellular DNA to regulate the expression of proteins. Nuclear Trans-Acting Factor,Trans-Acting Factors,Trans-Acting Factor,Trans-Activator,Transactivator,Transactivators,Factor, Nuclear Trans-Acting,Factor, Trans-Acting,Factors, Trans-Acting,Nuclear Trans Acting Factor,Trans Acting Factor,Trans Acting Factors,Trans Activator,Trans Activators,Trans-Acting Factor, Nuclear

Related Publications

U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Expression and purification of recombinant HIV-1 tat protein using HIV-1-tat specific monoclonal antibodies.
January 2000, Anticancer research,
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
High frequency of antibodies against recombinant HIV-2 Nef protein in HIV-2-positive and HIV-negative sera.
May 1992, AIDS (London, England),
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
January 1991, AIDS research and human retroviruses,
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Overexpression of recombinant HIV-1 Subtype C Tat and Nef in a Salmonella vaccine vector.
January 2013, The Pan African medical journal,
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.
January 1992, Archives of virology,
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Prevalence of anti-vif antibodies in HIV-1 infected individuals assessed using recombinant baculovirus expressed vif protein.
March 1997, Journal of medical virology,
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Virus-host interactions: role of HIV proteins Vif, Tat, and Rev.
January 2003, AIDS (London, England),
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
January 1990, Journal of acquired immune deficiency syndromes,
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
Antibodies to recombinant HIV-1 nef protein detected in HIV-1 infection as well as in nonrisk individuals.
January 1990, Disease markers,
U Wieland, and J E Kühn, and C Jassoy, and H Rübsamen-Waigmann, and V Wolber, and R W Braun
[Specific immune responses to human immunodeficiency virus type 1 Gag, Tat, Rev and Nef proteins].
March 2005, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
Copied contents to your clipboard!